Prospective comparative evaluation of clinical efficacy and safety of Intravesical gemcitabine-docetaxel versus BCG in adjuvant management of BCG-naive non-muscle invasive urothelial bladder cancer in Indian population
OncologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- International urology and nephrology
- Publicado em
- 17 mar 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Prospective comparative evaluation of clinical efficacy and safety of Intravesical gemcitabine-docetaxel versus BCG in adjuvant management of BCG-naive non-muscle invasive urothelial bladder cancer in Indian population
Aviral Srivastava, Sameer Trivedi, Yashasvi Singh, Ujwal Kumar, Lalit Kumar, Sahil Data, Anil Kumar, Satya Narayan Sankhwar
Descritores MeSH
- Deoxycytidine
- BCG Vaccine
- Urinary Bladder Neoplasms
- Carcinoma, Transitional Cell
- Docetaxel
- Antineoplastic Combined Chemotherapy Protocols
- Non-Muscle Invasive Bladder Neoplasms
- Adult
- Adolescent
- Administration, Intravesical